10% Owner of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), Takeda Pharmaceutical Co Ltd, sells 2,826 shares worth $99,080
According to Phathom Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 16 06:06 AM, company 10% Owner, Takeda Pharmaceutical Co Ltd disclosed selling 2,826 shares at a cost of $35.06. At the time of this transaction (Jun 14), this trade was worth $99,080 in total. As of Jun 14, Takeda Pharmaceutical Co Ltd now owns 935,886 shares in total worth about $32,475,244.200000003.
For the last few recent trades made by Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) 10% Owner, Takeda Pharmaceutical Co Ltd, we have the following information:
- SEC Form 4 filing: Jun 09: Sold 1,191 shares at the rate of $35.28 per share. Total worth of this trade was $42,018. Total number of shares owned as of Jun 09 were 940,814
- SEC Form 4 filing: Jun 10: Sold 2,102 shares at the rate of $35.14 per share. Total worth of this trade was $73,864. Total number of shares owned as of Jun 10 were 938,712
- SEC Form 4 filing: Jun 07: Sold 2,264 shares at the rate of $35.05 per share. Total worth of this trade was $79,353. Total number of shares owned as of Jun 07 were 942,105
Posted by
George Daniels
on Wednesday June 16 2021, 11:56 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
